Findings: More than 70% of CRC survivors received recommendations for routine checkups, surveillance colonoscopy, or other cancer screenings after completing CRC treatment, and 18%-22% received no such recommendations. Recommendations were sometimes given in writing. Receiving a recommendation for a specific type of follow-up was associated with greater adherence to corresponding guidelines for routine checkups, colonoscopy, mammography, and Papanicolaou testing. Receiving written (versus unwritten) recommendations led to greater adherence only for colonoscopy.
Conclusions: Most CRC survivors reported receiving recommendations for long-term medical follow-up and largely adhered to guidelines for follow-up. Receiving a health professional's recommendation for follow-up was consistently associated with patient adherence, and limited evidence showed that recommendations in written form led to greater adherence than unwritten recommendations.
Implications for Nursing: Given the increasingly important role of the oncology nurse in survivorship care, nurses can be instrumental in ensuring appropriate surveillance and follow-up care among CRC survivors. Conveying recommendations in written form, as is done in survivorship care plans, may be particularly effective. Compared with non-cancer controls, cancer survivors generally report higher rates of recommended cancer screenings (Bellizzi, Rowland, Jeffery, & McNeel, 2005; Fairley, Hawk, & Pierre, 2006; Hudson et al., 2009; Trask et al., 2005) . However, a systematic review on posttreatment surveillance of CRC survivors concluded that 20%-49% of survivors are nonadherent with recommendations for surveillance colonoscopy at five years postdiagnosis, and as many as 23% of survivors attend fewer than the number of recommended office visits (Carpentier, Vernon, Bartholomew, Murphy, & Bluethmann, 2013) . Given the potential health benefits (e.g., increased survival) associated with undergoing recommended surveillance after CRC treatments (Figueredo et al., 2003; Jeffery, Hickey, & Hider, 2007; Renehan, Egger, Saunders, & O'Dwyer, 2002; Tjandra & Chan, 2007) , underuse of appropriate follow-up is an issue of growing public health concern.
Research has revealed that CRC survivors who are African American, under-or uninsured, and who have more comorbidities are among the least likely to undergo post-treatment surveillance (Carpentier et al., 2013; Hudson et al., 2009; Rolnick et al., 2005; Rulyak, Mandelson, Brentnall, Rutter, & Wagner, 2004) . Other characteristics have been inconsistently reported across studies, and a need remains to identify modifiable factors associated with follow-up care for CRC survivors.
